Tech Company Financing Transactions
Persist AI Funding Round
Persist AI, based in Woodland, secured $4 million from 2048 Ventures, Fellows Fund and Innospark Ventures.
Transaction Overview
Company Name
Announced On
8/4/2023
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Seed
Investors
Proceeds Purpose
Drug formulation has long been overlooked despite being a crucial part of drug development. Persist's technology allows them to rapidly screen formulations, develop AI models that optimize the formulations, and then scale up formulations for human clinical use. We're excited to invest in this groundbreaking technology,
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1100 Main St 300-PB
Woodland, CA 95695
USA
Woodland, CA 95695
USA
Phone
Undisclosed
Website
Email Address
Overview
Developing extended-release PLG drug formulations takes $10M+ and 5-10 years. We enable drug manufacturers and CROs to shorten formulation discovery time by 30-50% by utilizing our automation and machine learning platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Karthik Raman
Chief Operating Officer
Christopher Shelner
Browse more venture capital transactions:
Prev: 8/4/2023: Eye Mantra venture capital transaction
Next: 8/6/2023: AMOpportunities venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs